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Abstract 
 
The neuromuscular junction (NMJ) exhibits high morphological and functional plasticity. In 
the mature muscle, the relative levels of physical activity are major determinants of NMJ 
function. Classically, motor neuron-mediated activation patterns of skeletal muscle have 
been thought of as the major drivers of NMJ plasticity and the ensuing fiber-type 
determination in muscle. Here we use muscle-specific transgenic animals for the peroxisome 
proliferator-activated receptor γ co-activator 1α (PGC-1α) as a genetic model for trained mice 
to elucidate the contribution of skeletal muscle to activity-induced adaptation of the NMJ. We 
find that muscle-specific expression of PGC-1α promotes a remodeling of the NMJ, even in 
the absence of increased physical activity. Importantly, these plastic changes are not 
restricted to post-synaptic structures, but extended to modulation of pre-synaptic cell 
morphology and function. Therefore, our data indicate that skeletal muscle significantly 
contributes to the adaptation of the NMJ subsequent to physical activity. 
 
3 
Introduction 
 
The neuromuscular junction (NMJ) is a complex structure that mediates the cross-talk 
between motor neurons and muscle fibers. The embryonic and post-natal installation of 
NMJs has been studied extensively and key factors that regulate NMJ assembly in this 
context have been described, including agrin and acetylcholine, membrane protein 
complexes and extracellular matrix components as well as various neurotrophic factors1-3. At 
least some of these regulators are also responsible for guiding NMJ formation in 
denervation-reinnervation cycles that are observed in fiber damage, several muscle 
dystrophies or in the aging process4,5. Interestingly, while a dominant role for motor neurons 
in NMJ formation has been postulated, an increasing amount of evidence highlights the 
important contribution of skeletal muscle to the proper installation of the NMJ2,6-8. For 
example, prepatterning by primitive, aneural acetylcholine receptor (AChR) clusters on the 
muscle fiber membrane might help axonal guidance9. Likewise, skeletal muscle-specific 
receptor tyrosine-protein kinase (MuSK) and low-density lipoprotein receptor-related protein 
4 (Lrp4), two key components involved in post-synaptic agrin action, mediate retrograde 
signaling from the muscle to the motor neuron that is crucial for presynaptic differentiation of 
the NMJ during embryonic and postnatal development10. At least studies in Drosophila 
suggest that these proteins might also be involved in late stage NMJ plasticity11; however, 
this hypothesis remains to be substantiated Drosophila as well as in vertebrates. 
Curiously, in contrast to the widely accepted important contribution of skeletal muscle to NMJ 
formation in development and re-innervation, the role of this organ in mediating plastic 
changes of the mature NMJ is much less appreciated. For example, morphological and 
functional adaptations of the NMJ to endurance training improve neuromuscular transmission 
and thereby contribute to an increased fatigue resistance12,13. The neuromuscular exercise 
plasticity however has almost exclusively attributed to the rate and amplitude of myocellular 
calcium transients that are triggered by distinct patterns of motor neuron firing14,15. Thus, 
exercise adaptations of the NMJ that ultimately lead to a metabolic and myofibrillar fiber-type 
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switch towards oxidative, high endurance muscle fibers are thought to be dominantly 
controlled by the neuronal input16. Accordingly, the plastic changes of NMJs in the trained 
neuromuscular context have been extensively characterized and include adaptations in 
endplate size, sprouting of nerve terminal branches, and electrophysiological kinetics17-19. 
However, the anterograde and retrograde signals involved in this remodeling remain largely 
enigmatic. Similarly, potential contributions of skeletal muscle to these plastic changes have 
not been studied. 
Overexpression of the peroxisome proliferator activated receptor  co-activator 1 (PGC-1α) 
in cultured muscle cells is sufficient to promote postsynaptic NMJ gene transcription and the 
formation of aneural AChR clusters. Moreover, skeletal muscle-specific gain- and loss-of-
function mouse models for PGC-1α exhibit altered expression of postsynaptic NMJ genes in 
muscle in vivo20. However, the consequence of altered muscle PGC-1α expression on NMJ 
morphology and function in vivo has not been assessed to date. 
Besides controlling postsynaptic NMJ gene expression, PGC-1α is a key regulatory nexus of 
endurance exercise adaptation in skeletal muscle. Accordingly, PGC-1α levels are strongly 
regulated by physical activity21. Upon activation, PGC-1α promotes many, if not all of the 
adaptations of muscle to endurance training, including increased mitochondrial biogenesis 
and oxidative metabolism, vascularization and a switch towards type I and IIa oxidative, high 
endurance muscle fibers22-24. Inversely, muscle-specific PGC-1α knockout mice exhibit 
features of pathological inactivity such as a switch towards glycolytic muscle fibers, reduced 
exercise capacity, fiber damage and local as well as systemic inflammation25,26. Based on the 
ability to promote a trained phenotype even in inactive muscle, overexpression of PGC-1α 
exerts a beneficial therapeutic effect in different contexts of muscular wasting, including 
Duchenne muscular dystrophy20, denervation-induced fiber atrophy, statin-mediated muscle 
dysmorphology, sarcopenia27 or amyotrophic lateral sclerosis28,29. 
To assess the contribution of skeletal muscle to the plasticity of adult NMJ morphology and 
function, we now studied the muscle-specific PGC-1α transgenic mice as a genetic model for 
endurance exercise. Even though these animals exhibit a trained phenotype, the PGC-1α 
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transgenics are not hyperactive and hence do not exhibit increased motor neuron firing when 
kept in a sedentary state30. This allows a dissociation of the effects from skeletal muscle and 
motor neurons on the NMJ in a mouse model of endurance exercise. Surprisingly, our 
findings demonstrate a hitherto underappreciated role for skeletal muscle to modulate NMJ 
plasticity both post- and pre-synaptically by improving NMJ integrity and function. Thus, in 
the adult neuromuscular system, shifts in the phenotype of the muscle fibers significantly 
contribute to the NMJ remodeling by activating a novel retrograde signaling. 
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Results 
 
Transgenic PGC-1α expression in different tissues 
In the transgenic animals, the expression of PGC-1α is driven by the muscle creatine kinase 
(MCK) promoter. To ensure muscle specificity of expression, we measured PGC-1α 
expression in the MCK mice using the WT samples as reference. As expected, the relative 
PGC-1α mRNA expression was highest in the predominantly glycolytic muscles tibialis 
anterior (TA), extensor digitorum longus (EDL), sternocleidomastoid (SCM) and levator auris 
longus (LAL), followed by the more mixed muscle beds in gastrocnemius and diaphragm 
(Fig. 1). The over-expression of PGC-1α was not significantly elevated in MCK mice in the 
oxidative soleus and transversus abdominis (TVA) muscles. Important for the present study, 
neuronal tissue, including spinal cord and brain, exhibited indistinguishable levels of PGC-1α 
transcript in WT and MCK animals thus confirming the muscle specificity of the transgenic 
PGC-1α expression in this mouse line. 
 
Elevated muscle PGC-1α modifies NMJ morphology 
The effect of muscle PGC-1α on postsynaptic gene expression in muscle cells and on 
formation of aneural AChR clusters in vitro has been demonstrated previously20 We now 
studied the consequences of elevated expression of PGC-1α in skeletal muscle on NMJ 
morphology in vivo. AChRs aggregates in the post-synaptic membrane, typically pretzel-
shaped, were stained with AF488-α-bungarotoxin (α-Bgtx), a very potent ligand for AChR 
(visualized in green). The motor neuron was labeled using an anti-neurofilament antibody 
revealed by a cyanin 5-conjugated secondary antibody (shown in red) (Fig. 2a). 
Quantification of the AChR clusters revealed a significantly smaller area in the glycolytic EDL 
and SCM of the MCK mice compared to their WT littermates (Fig. 2b). In contrast, the 
already smaller area of the postsynaptic endplates in the more oxidative diaphragm and 
soleus muscles was unchanged between MCK and WT animals (Fig. 2b). 
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NMJs always present a certain percentage of abnormalities at the post-and pre-synaptic 
levels. For example, the pretzel shape can be irregular, fragmented, or the density of the 
clusters can be faint, a sign of decreased AChR intensity. The percentage of structural NMJs 
deformities increases as the mouse ages and can be rectified by caloric restriction or 
exercise18. Similar to the improvement mediated by these interventions, the post-synaptic 
architecture of the NMJs was also significantly improved in the young MCK mice (Fig. 2c-f). 
In particular, SCM and diaphragm muscles of MCK animals displayed a reduction of faint 
pretzels (Fig. 2c) and the number of fragmented clusters (Fig. 2d) when compared to the WT 
counterparts while no significant differences were detectable in EDL and soleus muscles. 
Likewise, overexpression of PGC-1α in skeletal muscle increased the number of innervated 
NMJs with clear co-localization of the AChR and the motor neuron signal in SCM and 
diaphragm (Fig. 2e) as well a reduction of sprouts, nerve terminals that do not terminate 
within an AChR cluster in EDL and diaphragm (Fig. 2f) of MCK mice. 
 
PGC-1α-mediated changes in the ultrastructure of the NMJ 
Our data indicate that muscle PGC-1α improves NMJ morphology on the histological level. 
Importantly, structural and functional stabilization of the NMJ is to a large extent governed by 
the total area of interface between the motor neuron and the muscle and hence the number 
and size of synaptic folds. Therefore, to investigate how PGC-1α expression in muscle could 
affect NMJ structure, we studied the synaptic folds on the ultra-structural level using 
transmission electron microscopy (TEM) of the synaptic regions of SCM and soleus muscle 
(Fig. 3a-f). Interestingly, the NMJs in the SCM of MCK mice not only exhibited more folds per 
individual synapse (Fig. 3a), but also a significant increase in the average length of these 
synaptic folds (Fig. 3b), as illustrated by a representative TEM picture shown in Fig 3c. To 
confirm the increase in fold density in the NMJ from MCK NMJs, we measured the 
expression of the NaV1.4 channel concentrated in the depths of the folds by western blot (Fig 
3d, see Supplementary Fig. 1 for representative full-sized Western blots). The expression of 
NaV1.4 was correlated with the fold quantification, being higher in the muscle of transgenic 
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animals. In contrast, the number and average length of the synaptic folds in soleus muscle of 
the MCK mice were not different from those of the WT controls (Fig. 3e and 3f, respectively) 
correlating with the difference in PGC-1α expression in SCM, but not the soleus of MCK 
compared to WT mice. 
 
Muscle PGC-1α promotes slow-type NMJ function 
The morphological and ultra-structural analysis of the NMJ in MCK vs. WT mice not only 
suggests stabilization, but also a shift towards slow-type NMJs in the MCK mice, for example 
indicated by the smaller end plate size in these animals. As a next step, we therefore wanted 
to test whether the morphological changes induced by overexpressed PGC-1α in skeletal 
muscle were sufficient to trigger functional adaptations of motor neuron-muscle fiber 
interaction. First, compound muscle action potentials in response to repetitive nerve 
stimulation were assessed by electromyography. Specifically, the train of compound action 
potentials following direct stimulation of the sciatic nerve with a frequency of 50 Hz was 
recorded in the gastrocnemius of WT and MCK animals (Fig. 4a and 4b, respectively). 
Interestingly, while the amplitude of the first response was similar in the MCK and WT 
animals, the amplitude and area under the curve of the successive responses showed a 
significant decrement in the WT animals that was much lower in the MCK mice (Fig. 4c). 
To refine the functional studies, we subsequently investigated neurotransmission at the NMJ 
of the glycolytic LAL, which exhibits similar morphological NMJ plasticity in MCK mice to the 
leg glycolytic muscles and the oxidative TVA muscle with unchanged morphological 
properties between the two genotypes (Supplementary Fig. 2) First, we measured muscle 
resting membrane potential and found no significant differences between MCK and WT mice 
in either muscle (Supplementary Table 1). Then, when studying the spontaneous miniature 
end-plate potentials (mEPP) in LAL, a significantly slower mEPP rise time in MCK mice (0.78 
± a standard deviation of 0.03 s) in comparison with WT (0.68 ± a standard deviation of 0.02 
s) was observed (p = 0.03, T test), while no significant differences in mEPP amplitude, 
frequency or signal decay constant were found (Fig. 5a). Similarly, the rising time of evoked 
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endplate potentials (EPPs) in the LAL of MCK mice was significantly slower (0.75 ± a 
standard deviation of 0.02 s) than in WT (0.66 ± a standard deviation of 0.02 s) (p = 0.0085), 
while the amplitude and decay time constant of the EPPs remained unchanged in MCK mice 
(Fig. 5b). As EPPs are slower in slow muscles than in fast muscles31, we next measured the 
properties of mEPPs and EPPs in the oxidative TVA muscle (Supplementary Figure 3). As 
expected, the mean rising times of mEPPs and EPPs in WT TVA were slower than in WT 
LAL muscles (Tables 1 and 2), but not significantly different to those values measured in 
MCK LAL muscles. On the other hand, no difference in the rising times of spontaneous and 
evoked potentials was found between WT and MCK mice in the TVA (Tables 1 and 2). 
Short-term synaptic plasticity at the NMJ of the LAL muscle was tested by repetitive trains of 
stimuli of 1s, at 100 Hz (Fig. 5c). No differences in paired-pulse ratio (PPR) at inter-stimulus 
intervals (ISI) ranging from 10-200 ms were observed between the genotypes (Fig. 5c), 
suggesting no differences in synaptic release probabilities. In contrast, steady-state 
depression at the end of the 1s, 100 Hz train of stimuli was significantly lower in the MCK (39 
± a standard deviation of 2%) compared to WT (48 ± a standard deviation of 3%) mice (p = 
0.03, T test) (Fig. 5c). The ability of the MCK motor neuron terminals to sustain 
neurotransmitter release more efficiently than their WT counterparts became evident even 
after a few stimuli. For example, smaller depression after 10 repetitive stimuli was observed 
in the MCK mice, as a trend at 20 Hz (p=0.054, T test), and with statistical significance at 50 
Hz (p = 0.014, T test) and 100 Hz (p = 0.004, T test) (Fig. 5c). In motor nerve fibers that 
innervate slow (type I) muscle fibers neurotransmitter release is better sustained than in 
nerve terminals that innervate fast muscle fibers. This has been attributed to a larger 
synaptic vesicle pool size and lower quantal content (the number of quanta of 
neurotransmitter released per action potential) in slow motor neurons23. Therefore, we next 
compared the quantum content in the LAL of MCK and WT animals (Fig. 5b), and found that 
it was significantly smaller in MCK (34.7 ± a standard deviation of 1.8) than in WT (45.8 ± a 
standard deviation of 3.6) terminals (p = 0.01, T test). Therefore, the reduction in the number 
of fused vesicles per action potential, probably, contributed to less depression in MCK LAL 
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terminals. This compensation was further confirmed when the cumulated number of fused 
synaptic vesicles during 100 Hz stimulation was calculated in both genotypes and not 
statistical differences were obtained (Supplementary Table 2). Finally, we also estimated size 
of the readily-releasable pool (RRP) of synaptic vesicles32 in the nerve terminals of the LAL 
and found no differences between MCK and WT mice (Supplementary Table 3), suggesting 
that if the overexpression of PGC-1 induces an increase of synaptic vesicle that should be 
at the level of the reserve pool and not at the RRP. 
In the oxidative TVA, a significant increase in the amplitude of the spontaneous mEPPs as 
well as an increase in the decay time constant of the evoked EPPs was found in MCK mice 
(Supplementary Fig. 3). Finally, short-term depression after 10 repetitive stimuli at 50 Hz was 
reduced in the TVA of MCK animals compared to WT animals, while the rest of the 
electrophysiological parameters did not differ significantly between the genotypes in this 
muscle (Supplementary Fig. 3). 
 
Pre-synaptic remodeling of the NMJ by PGC-1 
The functional data obtained by the single motor neuron-muscle fiber-based 
electrophysiology strongly implies that the nerve endplates in the MCK animals with muscle-
specific overexpression of PGC-1 not only undergo a post-synaptic, but also a pre-synaptic 
remodeling. To substantiate this hypothesis, we studied the pre-synapse in more detail. 
Quantification of the nerve terminal branches within the region of the NMJ revealed a 
significantly higher number in nerve branches as well as an increased total length and 
branching complexity in the SCM of MCK animals compared to WT mice (Fig. 6a). These 
findings indicate a change in the pre-to-post-synaptic coupling in the PGC-1 muscle-specific 
transgenics. In fact, increased length of branching is usually accompanied by an increase in 
the number of ACh-containing vesicles in the pre-synaptic part in order to store more 
neurotransmitter. First, we quantified the number of synaptic vesicles using TEM (Fig. 6b). 
We observed a significantly higher number of synaptic vesicles in nerve terminals of the 
glycolytic SCM muscle of MCK mice compared to WT animals, but no significant differences 
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in terminals from the oxidative soleus muscle (Fig. 6c). Interestingly, the protein expression 
of synaptophysin (Syp), a pre-synaptic regulator of vesicle fusion, was likewise differentially 
expressed in the TA and SCM of MCK animals compared to WT mice (Fig. 6d). It was 
previously shown that the over-expression of PGC-1 in the muscle increased the frequency 
of motor neuron expressing the synaptic vesicle protein SV2A33. By isolating the synaptic 
area in the SCM muscle, we could confirm an increase in the expression of this protein in the 
MCK samples compared to their WT counterparts (Fig. 6e). 
Importantly, both acetylcholine biosynthesis and synaptic vesicle assembly are energy 
consuming processes. To assess whether the structural and functional changes of the pre-
synapse are accompanied by a corresponding adaptation of the metabolic properties, 
mitochondrial size and morphology was quantified with TEM. Intriguingly, a significant 
increase in the mitochondria volume density was observed in the transgenic animals (Fig. 
6f). This was accompanied by a prominent reduction in the number of mitochondria of the 
smallest volume density range, which was compensated by an increase in the proportion of 
mitochondria with a high volume density (Fig. 6g). In contrast, no statistically significant 
difference in average surface (cristae) density was found (Fig. 6h). Strikingly, even in the 
oxidative soleus muscle, a significant increase in pre-synaptic mitochondrial volume density 
was observed, while mitochondrial surface density was unchanged in the active zone of the 
motor neuron innervating Soleus (Supplementary Fig. 4). After pre-synaptic acetylcholine 
release, relative acetylcholine esterase activity in the neuromuscular cleft determines the rate 
of neurotransmitter breakdown and hence removal from the cleft. In contrast to the clear pre- 
and post-synaptic differences, acetylcholine esterase activity in the synaptic cleft is 
statistically indistinguishable between the two genotypes in any of the muscles studied (Fig. 
6i and Supplementary Fig. 5). 
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Discussion 
 
In the mature skeletal muscle tissue, activity-driven plasticity is the most important cause for 
NMJ remodeling12. Nevertheless, despite the well-documented modulation of NMJ structure 
and morphology in response to altered neuromuscular activity, very little is known about the 
molecular processes that control this type of NMJ plasticity. Historically, altered firing 
patterns of the motor neuron have been implicated as exclusive source of the remodeling of 
the neuromuscular interface and the ensuing adaptations in the muscle fiber34, e.g. a switch 
towards oxidative and glycolytic muscle fibers caused by altered intramyocellular calcium 
transients in endurance and resistance training, respectively15. In contrast to the 
developmental aspects of NMJ installation, the contribution of skeletal muscle fibers to these 
adaptive processes has been only rudimentarily studied. In recent years however, our 
understanding of the molecular mechanisms that underlie skeletal muscle cell plasticity has 
been tremendously expanded. For example, skeletal muscle is now widely recognized as an 
endocrine tissue that releases auto-, para- and endocrine hormones, so-called myokines35. 
Furthermore, we could show that intramyocellular calcium handling is not only controlled by 
motor neuron input but also cell-autonomously modulated by PGC-1α30. In the present study, 
we now provide strong evidence of a significant contribution of skeletal muscle to pre- and 
postsynaptic remodeling of the NMJ through elevated activity of the coactivator PGC-1α. In 
mice with skeletal muscle-specific overexpression of PGC-1α, the NMJ is altered 
morphologically, structurally and functionally despite unchanged locomotion and hence motor 
neuron-mediated activation of muscle fibers. Moreover, these mice exhibit a similar muscle 
fiber size distribution as control animals36: a change in fiber size thus is not the underlying 
cause of altered NMJ properties. Importantly, the extent of the plastic changes correlates 
with the relative overexpression of PGC-1α in muscles with different fiber type 
characteristics. For example, major rearrangements of the NMJs are found in the glycolytic 
SCM with high transgenic overexpression of PGC-1α compared to the minor alterations in 
the oxidative soleus where transgenic elevation of PGC-1α is minimal. 
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Morphology and function of the NMJs in the MCK mice resemble those of slow-type NMJs 
innervating oxidative muscle beds, e.g. as indicated by the smaller endplate size37. 
Functionally, this switch towards slow-type NMJs allows a more sustained firing pattern that 
is typical for the high endurance contractions in slow muscles, at least in part by a higher 
number of synaptic vesicles and increased mitochondrial volume density in the active zone 
combined with a smaller quantum content. This modulation in synaptic vesicle handling in the 
active zone of the motor neuron is further underlined by the distinct expression of proteins 
involved in synaptic vesicle function such as synaptophysin and the slow-type NMJ enriched 
synaptic vesicle protein 2A (SV2A), which has previously been reported to be increased in 
NMJs of MCK animals33. Similarly, the changes in kinetics of the mEPPs and EPPs, in 
particular the increase in rise time, are typical for slow-type NMJs31,38. Finally, our data also 
reveal the increase in pre-synaptic nerve terminal branching that is linked to activity-driven 
adaptations of the NMJ12,17. Importantly, the reduction in quantum content is not indicative of 
failure in neurotransmission given the high safety factor in the NMJ, the unchanged high 
amplitude of the post-synaptic end-plate potential, the reduced depression in the amplitude 
of the responses following repetitive nerve stimulation in the EMG and in the intracellular 
recordings and finally illustrate the fatigue resistance in PGC-1α-overexpressing muscles in 
and ex vivo. Thus, muscle PGC-1α induces many post- and, importantly also pre-synaptic 
changes that have been linked to activity-driven NMJ plasticity in the adult muscle. 
The large amplitude of the EPP that we observe may be related with the mouse background. 
In our experience, and in that of others, EPP amplitude in mice with a C57BL/6 background 
have larger EPP than FVB mice 39. This large amplitude was also confirmed in a number of 
fibers in which two-electrode voltage clamp recordings were obtained. Typical peak currents 
in WT mice were 70-80 nA while mean input resistance was 0.84 M. This results in EPP 
amplitudes of 58-68 mV. 
Intriguingly, PGC-1α-mediated modulation of NMJ morphology also closely resembles the 
beneficial effects of caloric restriction and exercise on age-related deterioration of the 
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neuromuscular interface18. Thus, we observed an improvement in morphological NMJ 
integrity both in post-synaptic features such as acetylcholine receptor density and pretzel 
fragmentation, as well as pre-synaptically in terms of innervation and sprouting. On the ultra-
structural level, the increase in synaptic fold number and length in the MCK animals indicates 
a structural stabilization as well as an enhancement of the synaptic transmission triggered by 
overexpressed muscle PGC-1α40. Interestingly, exercise affects only the NMJs of a subgroup 
of aged muscles whereas the effect of caloric restriction is more ubiquitous18. Similarly, 
muscle-specific overexpression of PGC-1α had distinctive outcomes on NMJ morphology 
and function in different muscles. In our experimental context of sedentary mice, these 
differences could be caused by the relative usage of the muscles that were characterized in 
the animals. It thus might be interesting in future studies whether bona fide exercise of the 
MCK mice extends the remodeling of the NMJs beyond those that were observed in the 
sedentary animals. A corresponding amplification of muscle-specific transgenic expression of 
PGC-1α by treadmill running has previously been reported in regard to diet-induced 
peripheral insulin resistance. 
 
Our finding that muscle PGC-1α not only remodels the post-synapse, but also triggers a 
significant pre-synaptic adaptation of the NMJ obviously suggest the production of a PGC-1α-
dependent neurotrophic factor that mediates a local, retrograde signal from muscle to the 
motor neuron. While a number of retrograde signals have been identified in the formation of 
NMJs during development, very little about the role of skeletal muscle and hence about 
putative retrograde signaling mediators is known in physiological NMJ plasticity in the adult 
muscle. We have tested some candidate retrograde signaling molecules that have been 
described in the context of developmental NMJ differentiation2, including several extracellular 
matrix components, but did not observe any differences in gene expression between MCK 
and WT mice (Supplementary Fig. 6). Therefore, it is conceivable that different factors 
convey a retrograde signal in the mature compared to the developing NMJ. However, while 
we would expect a transcriptional response due to overexpression of the transcriptional 
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coactivator PGC-1α, our findings obviously do not exclude posttranscriptional mechanisms to 
contribute to retrograde signaling in our experimental context. Similarly, the increase in PGC-
1α-mediated AChR expression and clustering, MuSK or some other post-synaptic protein 
might contribute to the retrograde signaling. Nevertheless, it is also possible that so far 
uncharacterized neurotrophic factors could be involved in physiological NMJ plasticity and 
future studies will aim at identifying those. 
 
In summary, we now for the first time provide strong evidence for a significant contribution of 
skeletal muscle to physiological NMJ plasticity in adult muscle, both on the post- as well as 
on the pre-synaptic side. In particular, it is conceivable that PGC-1α, a regulatory nexus in 
metabolic and myofibrillar endurance exercise adaptation in muscle, also controls activity-
dependent remodeling of the NMJ and contributes to the attenuation of the age-related 
deterioration of neuromuscular morphology and function by exercise. PGC-1α has previously 
been described to ameliorate muscle atrophy and fiber damage in different pathological 
contexts, including Duchenne muscular dystrophy20. In Duchenne muscular dystrophy, NMJ 
dysfunction is thought to contribute to the disease pathology. While the exact mechanism by 
which skeletal muscle-specific overexpression of PGC-1α improves muscle fiber integrity and 
function in mdx animals, the mouse model for Duchenne muscular dystrophy, PGC-1α-
mediated stabilization of the NMJ could certainly be a part of this therapeutic effect. Similarly, 
the prevention of sarcopenia in muscle-specific PGC-1α transgenic mice could be due to the 
functional improvement in the NMJ as has been shown in old animals27. In contrast, skeletal-
muscle specific overexpression of PGC-1α ameliorated the muscle pathology of an 
amyotrophic lateral sclerosis (ALS) mouse model, but was insufficient to extend survival29. 
These findings indicate that the effect of muscle PGC-1α on NMJ stability might be 
insufficient in very severe motor neuron diseases, but could be therapeutically beneficial in 
pathologies with a milder motor neuron phenotype or with secondary deterioration of the 
NMJ. Therefore, identification of pharmacological agents that activate PGC-1α in human 
muscle or that target the muscle-derived factors which mediate the retrograde signaling in 
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this context, is of high clinical importance. Thus, similar to our current understanding of the 
potential deployment of “exercise mimetics” in the treatment of metabolic diseases, such 
compounds might also be excellent adjuvant interventions to facilitate and amplify bona fide 
exercise in patients with impaired exercise tolerance. 
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Methods 
 
Animals: 
All experiments were performed on male, 6- to 8-weeks-old wildtype and transgenic mice (all 
mice obtained from in-house breeding) where the PGC-1α expression is driven by a muscle 
creative kinase (MCK) promoter (designated MCK mice, as opposed to the wild-type (WT) 
littermates)22. The animals were kept in a room with a 12/12 light/dark cycle, were fed a 
standard laboratory chow diet and had ad libitum access to water. All animal experiments 
were approved by the institutional as well as Swiss cantonal veterinary authorities according 
to the guidelines of the European Council Directive for the Care of Laboratory Animals. 
 
Tissue preparation: 
Isolated muscles were directly frozen in liquid nitrogen. Total RNA was extracted using 
TriReagent according to the Manufacturer’s protocol and treated with RNase-free DNase 
(Invitrogen). The concentration was adjusted and 1 μg of RNA was reverse-transcribed into 
cDNA using Superscript RT (Invitrogen) with random hexamer primers (Roche). Real-time 
PCR was performed with the Power Sybr Green Master Mix (Applied Biosystems) using the 
StepOne Plus Lightcycler (Applied Biosystems). The relative expression level for each gene 
of interest was estimated according to the ΔΔCt method, using the WT samples as reference 
and the expression of the TATA binding protein (TBP) as a calibrator. Real-time PCR primers 
are shown in Supplementary Table 4. 
For protein extraction, the frozen muscles or tissues were digested with lysis buffer (Tris HCl 
20 mM, NaCl 138 mM, KCl 2.7 mM, Glycerol 5 % v/v, NP40 1 % v/v, supplemented with a 
cocktail of protease inhibitors (Roche) and the protein concentration was quantified with the 
BCA protein assay kit (Pierce, Thermofisher). Proteins were resolved by SDS-PAGE, 
transferred to a PVDF membrane and incubated with an anti-synaptophysin antibody 
(Abcam, Ref. ab53166, 45 kD), anti-SCN4A antibody (Novus Biological, Ref NBP1-19008, 
208 kDa) and SV2A antibody (Novus Biological, Ref NBP1-46367, 88 kD). Tubulin 
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expression (Upstate Cell Signaling, Ref 05-829, 55 kDa) was used as loading control. The 
relative intensity of the bands of interest was analyzed by Image J, and expressed relative to 
the tubulin band intensity. The WT/tubulin level was set as 100%. 
To be able to measure the expression of pre-synaptic markers from the muscle samples, the 
synaptic part was stained with Alexa Fluor 488-coupled -bungarotoxin and micro-dissected 
under a binocular microscope. The isolated synaptic part was then processed as other 
samples for protein or RNA extraction. 
For immunofluorescence, soleus, extensor digitorum longus (EDL), diaphragm and 
sternocleidomastoid (SCM) were isolated. The collected muscles were fixed for 10 min at -
20°C in methanol, washed in PBS and incubated for 2 hours at room temperature in a 
blocking solution (PBS supplemented with 1 % BSA, 5 % Horse serum, 1 % Triton-x100, 0.1 
% NaN3). The whole muscles were then incubated overnight at 4°C with a mixture of primary 
antibody and Alexa Fluor 488-coupled α-bungarotoxin (Molecular Probe, Ref B13422) diluted 
1/10,000 in blocking solution. The polyclonal antibody against the neurofilament (Chemicon-
millipore, Ref AB1987) was used at a 1/1000 dilution and the polyclonal anti-synaptophysin 
(Dakocytomation Ref M7315) at 1/200. After 4 h of incubation with the adequate secondary 
antibodies, the muscles were whole-mounted on slides with a fluorescent mounting medium 
(Dako). The samples were observed under a confocal microscope (DMI6000, Leica) and 
maximum intensity projections of stacks were used to study the NMJ structure. The same 
settings were kept for all the samples (thickness of the scanned area, number of layers, gain 
and offset). 
The NMJ architecture characterization was based on the definitions given by Sanes and 
Lichtman18. More than 100 NMJs (n) from at least 3 animals (N) were counted. Pre-synaptic 
variables of NMJ included the number of branches identified at the nerve terminal, the total 
length of those branches, the average length per branch and the branching complexity 
obtained by multiplying the number of branches by the total length of those branches, and 
dividing that figure by 100 as described previously41. 
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For electrophysiology recordings, the levator auris longus (LAL) and transversus abdominis 
(TVA) muscles were dissected with their nerve branches intact and pinned to the bottom of a 
2 ml chamber, over a bed of cured silicon rubber (Sylgard, Dow Corning. Preparations were 
continuously perfused with a solution of 125 mM NaCl, 5 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 
25 mM NaHCO3, and 15 mM glucose under a continuous flow of a 5 % CO2/95 % O2 gas 
mixture. 
 
Synaptic fold quantification 
Synaptic fold lengths were determined for individual NMJs using Image J software and TEM 
images at 8500x magnification. Lengths were measured cursively from the edge of the 
synapse to the end of each fold using a Wacom CTH-470 pen tablet. Synaptic fold lengths 
and synaptic fold number per NMJ (N=9-16 per mouse) were averaged per mouse and 
subsequently between mice at the same genotype (WT=4, MCK=4 in SCM muscle). 
 
Volume and Surface Density of pre-synapse 
Volume and surface density of mitochondria within the neuromuscular junction was 
calculated according to methods previously described by Weibel and digitally adapted to 
Adobe Photoshop (Weibel 1979). Mitochondria and cristae structures within the NMJ were 
identified and outlined manually using a Wacom CTH-470 pen tablet. Volume density was 
determined in a test point system utilising a D64 grid (q2=16, PT=64, P’T=1024) using TEM 
images of 8500x magnification. Volume density (VV) is defined in the equation 1 as the ratio 
of test points residing within mitochondria (PM) and the total amount of test points within the 
NMJ (PNMJ).  
௏ܸ ൌ ெܲ ேܲெ௃⁄ 	ሺܧݍݑܽݐ݅݋݊	1ሻ 
Cristae density of mitochondria was measured at equal magnification in a test point system 
using a D576 grid (q2=16, PT=576, P’T=9216). Cristae density of individual mitochondria 
(SV(cr,mt)) is defined in equation 2 as the total amount of intersections between inner 
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mitochondrial membrane and test lines (Icr) divided by the product of the amount of points 
within the mitochondria (Pmt) and the actual length of fine test lines in μm (d). 
ܵ௏ሺ௖௥,௠௧ሻ ൌ ܫ௖௥ ሺ ௠ܲ௧⁄ ∙ ݀ሻ (Equation 2) 
Cristae density was determined in one mitochondrion randomly selected in each NMJ for a 
total of 9-16 NMJ per mouse. NMJ data for cristae and volume density were averaged per 
mouse and subsequently between mice at the same genotype (WT=4, MCK=3 in SCM 
muscle). 
 
AChE enzymatic activity measurement 
The AChE activity was measured using the Amplex® Red Acetylcholine/Acetylcholinesterase 
Assay Kit (Molecular Probes). Each reaction contained 200 μM Amplex Red Reagent 
containing 1 U/ml HRP, 0.1 U/ml choline oxidase and 100 μM acetylcholine. The choline 
generated from AChE activity is oxidized by choline oxidase to betaine and H2O2 that reacts 
with the Amplex Red reagent to generate a fluorescent product detected at 590 nm (N=3 for 
each experimental group). 
 
Electromyography 
Mice were anesthetized using sevofluorane. The electromyographic properties of the 
gastrocnemius were recorded using a Keypoint EMG machine (Meridian, Neurolite AG, 
Switzerland). Briefly, the sciatic nerve was directly repetitively stimulated by a train of 15 
stimulations (0.04 ms of duration, 10 mA of amplitude) in a supramaximal conditions at 50 Hz 
with 2 monopolar needle electrodes and the action potentials in the gastrocnemius muscle 
response were recorded using a needle electrode placed directly in the muscle belly. The 
decrement percentage in terms of amplitude and area was averaged for WT and MCK mice 
(N = 4 for each experimental group). 
 
Electrophysiology 
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The electrical stimulation and intracellular recording were performed as previously 
described42. Briefly, the nerve was stimulated by means of a suction electrode. The 
stimulation consisted of square-wave pulses at variable frequencies. A glass microelectrode 
filled with 3M KCl was connected to an intracellular recording amplifier (Neuro Data IR283, 
Cygnus technology) and used to impale single muscle fibers near the motor nerve endings. 
Evoked endplate potentials (EPP) and miniature EPPs (mEPPs) were recorded from different 
NMJs within the muscle as described previously. Muscle contraction was prevented by 
including in the bath 3-4 M -conotoxin GIIIB (Alomone Laboratories), a specific blocker of 
muscular voltage-gated sodium channels. The data were analyzed as previously described42. 
EPP Amplitudes were normalized to -70 mV and corrected for non-linear summation. 
 
Transmission electronic microscopy  
The samples were prepared and processed by the Center for Microscopy of the Basel 
University (ZMB, Basel, Switzerland). The muscles were fixed in a 3% paraformaldehyde, 
0.5% glutaraldehyde buffered solution for 1 hour and subsequently incubated in a 1% 
osmium tetroxid buffered solution. The slides were dehydrated in a graded EtOH series (50-
100%), infiltrated in 100% acetone, embedded in Epon and serially thin sectioned before 
staining with uranyl acetate and lead acetate. The samples were analyzed on a TEM 
Moragni 268D (Philips) at 80 kV. 
 
Statistical analysis 
The results are represented as mean ± SEM, unless otherwise stated. The MCK and WT 
samples were compared using the Student’s t test (two-tailed) and a p value < 0.05 was 
considered statistically significant. N=number of mice, n=number of pretzels or number of 
fibers.  
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Figure legends 
 
Figure 1. Level of expression of PGC-1α in different muscles from WT and MCK mice 
Relative PGC-1α mRNA levels in tissues from WT (white bars, n=3) and MCK-PGC-1α mice 
(grey bars, n=3) (6- to 8-weeks old). Total RNA was reverse transcribed and the level of 
expression of PGC-1α was determined by real-time PCR, relative to the TATA-Binding 
Protein (TBP) expression level, analyzed according to the ΔCt method. Each bar represents 
mean ± SEM. * p<0.05 (n=3, t test two tails) TA: tibialis anterior, EDL: extensor digitorum 
longus, SCM: sternocleidomastoidian, LAL: levator auris longus, Gastroc: gastrocnemius, 
Diaphr: diaphragm, TVA: transversus abdominis. 
 
Figure 2. Structural comparison of the NMJ from WT and transgenic mice. (a) 
Representative confocal stack image of fluorescently labeled NMJ in different muscles. 
Muscles were stained with AF488-coupled α-bungarotoxin to visualize AChRs (green) and 
anti-neurofilament antibodies coupled to cyanin 5 to stain the nerve part (red). Calibration 
bar: 200 μm (b) Mean area of the AChRs aggregates was determined by Image J in arbitrary 
units. Each bar represents mean ± SEM. * p<0.05 (N=3, t test two tails) (c-f) The frequency 
of faint AChRs clusters, highlighted by a white star Calibration bar: 50 μm (c), fragmented 
AChRs clusters Calibration bar: 1.5 μm (d), innervated pretzels Calibration bar: 40 μm (e) 
and sprouted AChRs clusters Calibration bar: 25 μm (f) was determined on confocal images 
stack. Each bar represents mean ± SEM from at least 100 NMJ from 3 mice * p<0.05 (N=3, 
n>100, t test two tails). White bars represent wt animals, grey bars transgenic mice. 
 
Figure 3. Synaptic folds characterization on the TEM images from WT and transgenic 
mice NMJs. (a) The average number of folds attached to synapses was determined for WT 
and MCK mice in SCM muscle. (b) Synaptic fold lengths from SCM muscles were scaled and 
measured with Image J and averaged. Each bar represents mean ± SEM. (n=4, t test two 
tails). (c) Representative TEM image of the NMJ area of SCM muscle from WT or MCK 
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animals. (d) Western Blot detection of the Nav1.4 expression in SCM muscles from WT and 
MCK animals. The relative band intensity was analyzed by Image J. The WT/tubulin ratio 
was set as 100 %. (e) The average number of folds attached to synapses was determined for 
WT and MCK mice in soleus muscle. (f) Synaptic fold lengths from soleus muscles were 
scaled and measured with Image J and averaged. Each bar represents mean ± SEM. (n=4, t 
test two tails). SF: Synaptic folds, m: mitochondria. 
 
Figure 4. Electromyographic properties of the gastrocnemius muscles in WT and MCK 
mice after repetitive nerve stimulation of the sciatic nerve. (a, b) Representative 
electromyography traces of WT (a) and MCK mice (B). (c) Average of the 1st peak amplitude 
in mV and the decrement (amplitude and area) calculated between the 1st and the 4th peak of 
the train of action potentials recorded in WT (white bars) and MCK animals (grey bars). Each 
bar represents mean ± SEM * p<0.05 (n=7, t test two tails). 
 
Figure 5. Electrophysiological properties of LAL muscles from WT or transgenic mice 
(a) The spontaneous neurotransmitter release of LAL muscle resembled the representative 
traces of mEPP in WT (black) and MCK-PGC-1α (gray) NMJs. Amplitude, frequency of 
mEPP and their rise and decay times were determined. (b) Evoked neurotransmitter release 
resembled the representative traces of EPP in WT (black) and MCK-PGC-1α (gray) NMJs. 
Amplitude, quantum content of EPP and their rise and decay times were determined. (c) The 
synaptic plasticity shows a representative trace of steady-state depression in WT (black) and 
MCK-PGC-1α (gray) mice. The pair-pulse-facilitation (PPF) at inter-stimulus-intervals(ISI) 
ranging from 10 to 200 ms and the steady-state depression were measured at the end of the 
train and normalized to the amplitude of the first EPP. The normalized depression after 10 
repetitive stimuli was measured between 0 and 100 Hz. The results are represented as mean 
± SEM. The numbers in the bars are n,N: number of fibers, number of mice. 
 
28 
Figure 6. Pre-synaptic remodeling of the NMJ by PGC-1. (a) The number of branches 
per AChRs cluster and the average length of the branches were determined on confocal 
images stack using Image J in arbitrary units on WT (white bars) and MCK (grey bars) mice. 
The complexity is defined as the branch number x the total branch length divided by 100. 
Each bar represents mean ± SEM from at least 100 NMJ from 3 mice * p<0.05 ** p<0.01 
(N=3, n>100, t test two tails). (b) Representative TEM picture illustrating the synaptic vesicle 
number in the SCM muscle from WT and MCK mice. (c) Quantification of synaptic vesicle 
number per m2 determined by Image J on WT (white bars) and MCK (grey bars) mice. Each 
bar represents mean ± SEM from at least 10 NMJ from 3 mice * p<0.05 (N=3, n>10, t test 
two tails. (d) Western blot detection of synaptophysin on protein extracts from different 
tissues of WT (W, white bars) and MCK (M, grey bars) animals. The relative band intensity 
was analyzed by Image J. The WT/tubulin ratio was set as 100 %. * p<0.05 (N=3). (e) 
Western blot detection of the synaptic vesicle 2A on SCM protein extract in WT and MCK 
mice. (f, g) Volume density of mitochondria within the NMJ was calculated according to 
Weibel 43 using a D64 grid (q2=16, PT=64, P’T=1024) at 8500x magnification. Individual NMJ 
data (N=9-16 per mouse) were averaged per mouse and subsequently between mice at the 
same genotype (WT=4, MCK=3). Unpaired t test. (h) The surface density of mitochondria 
(right) was calculated according to Weibel using a customized D576 Grid (q2=16, PT=576, 
P’T=9216).at 8500x magnification. Individual NMJ data (N=9-16 per mouse) were averaged 
per mouse and subsequently between mice at the same genotype (WT=4, MCK=3). 
Unpaired t test. (i) For SCM muscle, a kinetic of AChE activity was measured indirectly by 
detecting the fluorescence emitted at 590 nm for 3600 sec. Each point represents mean ± 
SEM. (N=3). 
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Table 1. Spontaneous neurotransmitter release in NMJs of LAL and TVA muscles:  
LAL  WT  MCK  p 
Amplitude (mV)  1.75 ± 0.32 (18,3)  1.76 ± 0.15 (21,4)  0.97 
Frequency (Hz)  0.68 ± 0.08 (18,3)  0.87 ± 0.08 (24,4)  0.11 
Rise time (ms)  0.68 ± 0.02 (11,3)  0.78 ± 0.03 (14,4)  0.03 * 
Decay time constant (ms)  2.09 ± 0.18 (11,3)  2.21 ± 0.13 (14,4)  0.58 
TVA  WT  MCK  p 
Amplitude (mV)  0.67 ± 0.04 (17,3)  0.98 ± 0.08 (17,3)  0.002 * 
Frequency (Hz)  1.06 ± 0.14 (17,3)  1.47 ± 0.16 (17,3)  0.07 
The results are represented as mean ± SEM. The numbers in the parenthesis are n,N: 
number of fibers, number of mice. 
 
Table 2. Evoked neurotransmitter release in NMJs of LAL and TVA muscles: 
LAL  WT  Tg  p 
Amplitude (mV)  75.9 ± 14.8 (18,3)  59.1 ± 6.1 (21,4)  0.31 
Quantum Content  45.8 ± 3.6 (18,3)  34.7 ± 1.8 (24,4)  0.011 * 
Rise time (ms)  0.66 ± 0.02 (18,3)  0.75 ± 0.02 (21,4)  0.0085 * 
Decay time constant (ms)  1.84 ± 0.06 (18,3)  1.96 ± 0.12 (21,4)  0.38 
TVA  WT  Tg  p 
Amplitude (mV)  43.1 ± 3.95 (17,3)  51.2 ± 3.4 (17,3)  0.126 
Quantum Content  64 ± 4.5 (17,3)  55.4 ± 4.1 (17,3)  0.167 
Rise time (ms)  0.78 ± 0.02 (17,3)  0.74 ± 0.02 (17,3)  0.15 
Decay time constant (ms)  1.92 ± 0.1 (17,3)  2.26 ± 0.1 (17,3)  0.019 * 
The results are represented as mean ± SEM. The numbers in the parenthesis are n,N: 
number of fibers, number of mice. 
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Supplementary Figures 
 
Supplementary Fig. 1. Representativ full-sized Western blots. (a) Western blot for 
synaptophysin in the TA and EDL muscles of WT (lanes 2, 4, 6, 8, 10 and 12) and MCK mice 
(lanes 1, 3, 5, 7, 9, 11).(b) Western blot for SV2A. (c) Western blot for tubulin. 
2 
 
Supplementary Figure 2. NMJ morphology of the LAL and TVA muscles. (a) Representative 
confocal stack image of fluorescently labeled NMJ in the LAL muscle. Muscles were stained with 
rhodamine-coupled α-bungarotoxin to visualize AChRs (red) and anti-neurofilament antibodies to 
3 
stain the nerve part (green). Calibration bar: 5 μm (b) Mean size of post-synaptic terminal areas in 
WT (White bars, n=32 terminals, 3 mice) and MCK (Grey bar, n=35 terminals, 3 mice). Each point 
represents mean ± SEM. (c) Representative confocal stack image of fluorescently labeled NMJ in 
the TVA muscle. Calibration bar: 3 μm (d) Mean size of pretzel areas in WT (White bars, n=106 
terminals, 3 mice) and MCK (Grey bar, n=113 terminals, 3 mice). Each point represents mean ± 
SEM. *p<0.05, t test two-tails. 
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Supplementary Figure 3. Electrophysiological properties of TVA muscles from WT or 
transgenic mice. (a) The spontaneous neurotransmitter release of LAL muscle resembled the 
representative traces of mEPP in WT (black) and MCK-PGC-1α (gray) NMJs. Amplitude, 
frequency of mEPP and their rise and decay times were determined. (b) Evoked neurotransmitter 
release resembled the representative traces of EPP in WT (black) and MCK-PGC-1α (gray) NMJs. 
Amplitude, quantum content of EPP and their rise and decay times were determined. (c) The 
synaptic plasticity shows a representative trace of steady-state depression in WT (black) and MCK-
PGC-1α (gray) mice. The pair-pulse-facilitation (PPF) at inter-stimulus-intervals(ISI) ranging from 
5 
10 to 200 ms and the steady-state depression were measured at the end of the train and 
normalized to the amplitude of the first EPP. The normalized depression after 10 repetitive stimuli 
was measured between 0 and 100 Hz. The results are represented as mean ± SEM. The numbers 
in the bars are n,N: number of fibers, number of mice. T test (*p<0.05). 
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Supplementary Figure 4. Pre-synaptic mitochondrial morphology in soleus muscles. 
Representative TEM picture illustrating the synaptic vesicle number and the mitochondria structure 
in the synaptic region of the soleus muscle from WT and MCK mice. Volume density (left panel) 
and surface density (right panel) in WT (white bars) and MCK mice (black bars). Volume density of 
mitochondria within the NMJ was calculated according to Weibel et al. using a D64 grid (q2=16, 
PT=64, P’T=1024) at 8500x magnification. The surface density of mitochondria (right) was 
calculated according to Weibel et al. using a customized D576 Grid (q2=16, PT=576, P’T=9216).at 
8500x magnification. Individual NMJ data (N=9-16 per mouse) were averaged per mouse and 
subsequently between mice at the same genotype (WT=4, MCK=3). Unpaired t test (*p<0.05).  
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Supplementary Figure 5. Acetylcholine esterase activity in different muscles. For each 
muscle, a kinetic of AChE activity was measured indirectly by detecting the fluorescence emitted at 
590 nm for 3600 sec. Each point represents mean ± SEM. (N=3). 
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Supplementary Figure 6. Level of gene expression in different muscles from WT and MCK 
mice. Total RNA was reverse transcribed and the level of expression of the genes of interest was 
determined by real-time PCR, relative to the TATA-Binding Protein (TBP) expression level, 
analyzed according to the ΔΔCt method. The expression level in the WT samples was set to 1. 
Each bar represents mean ± SEM. (n=3, t test two tails). 
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Supplementary Tables 
 
Supplementary Table 1: Muscle resting membrane potential in LAL and TVA muscles from WT 
and MCK mice. 
Vm (mV) WT MCK p 
LAL -66.2 ± 3.6 (18, 3) -61 ± 1.4 (24, 4) 0.22 
TVA -66.6 ± 2.3 (18, 3) -68.1 ± 1.4 (17, 3) 0.56 
The results are represented as mean ± SEM. The numbers in the parenthesis are n,N: number of 
fibers, number of mice. T-test. 
 
 
Supplementary Table 2: Cumulated released vesicles during 100 Hz, 1s train of stimuli in the LAL 
muscle from WT and MCK mice. 
WT MCK p 
3285 ± 272 vesicles (n, N=17, 3) 2840 ± 141 vesicles (n, N=24, 4) 0.159 
The results are represented as mean ± SEM. The numbers in the parenthesis are n,N: number of 
fibers, number of mice. T-test. 
 
 
Supplementary Table 3: Size of the Readily-Releasable Pool (RRP) of synaptic vesicles in LAL 
and TVA muscles from WT or MCK mice. 
RRP WT MCK p 
LAL 1744 ± 158 (n, N=17, 3) 1750 ± 126 (n, N=24, 4) 0.98 
TVA 1583 ± 98 (n, N=15, 3) 1565 ± 160 (n, N=15, 3) 0.93 
The results are represented as mean ± SEM. The numbers in the parenthesis are n,N: number of 
fibers, number of mice. T test. 
 
 
10 
 
Supplementary Table 4: Semiquantitative real-time PCR primer list. 
Gene 
Symbol 
Reference Forward primer Reverse primer 
mPpargc1a NM_008904.2 GTGACATAGAGTGTGCTGCTC ACTTCAATCCACCCAGAAAG 
mTBP NM_013684.3 ATATAATCCCAAGCGATTTGC GTCCGTGGCTCTCTTATTCTC 
mLrp4 NM_172668 GGCAAAAAGCAGGAACTTGT TCTACCCAGTGGCCAGAACT 
mAgrn NM_021604.2 GGCCTGGATCCTCAACACTA  AACCTGGGATCCACTTCACA 
mMuSK NM_001037127.2 GAACATCTATTCCGCAGACTACTACAA TCGGGCGGCATCCA 
mDok7 NM_172708.3 CCAGCACCTCCCGCTATG ACCCCGACGCGATGTG 
mGdnf NM_010275.2 TCTCGAGCAGGTTCGAATGG AAGAACCGTCGCAAACTTTACC 
mNGF NM_013609.2 TCTGTGTACGGTTCTGCCTG CAGCTTTCTATACTGGCCGC  
mCntf NM_170786.2 CCATCCACTGAGTCAAGGCT  CTGTAGCCGCTCTATCTGGC 
mNtf3 NM_008742.3 GCCACGGAGATAAGCAAGAA ACGGATGCCATGGTTACTTC 
 
